MA29816B1 - Composes de benzimidazole thiophene - Google Patents
Composes de benzimidazole thiopheneInfo
- Publication number
- MA29816B1 MA29816B1 MA30794A MA30794A MA29816B1 MA 29816 B1 MA29816 B1 MA 29816B1 MA 30794 A MA30794 A MA 30794A MA 30794 A MA30794 A MA 30794A MA 29816 B1 MA29816 B1 MA 29816B1
- Authority
- MA
- Morocco
- Prior art keywords
- thiophene compounds
- compounds
- benzimidazole thiophene
- benzimidazole
- preparing
- Prior art date
Links
- OHNAITIAQLQHJY-UHFFFAOYSA-N 1h-benzimidazole;thiophene Chemical class C=1C=CSC=1.C1=CC=C2NC=NC2=C1 OHNAITIAQLQHJY-UHFFFAOYSA-N 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
L'INVENTION CONCERNE DES COMPOSÉS DE BENZIMIDAZOLE THIOPHÈNE, DES COMPOSITIONS PHARMACEUTIQUES CONTENANT LESDITS COMPOSÉS, DES PROCÉDÉS PERMETTANT DE PRÉPARER LESDITS COMPOSÉS ET L'UTILISATION LESDITS COMPOSÉS EN TANT QU'AGENTS PHARMACEUTIQUES.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71433705P | 2005-09-06 | 2005-09-06 | |
| US78624406P | 2006-03-27 | 2006-03-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA29816B1 true MA29816B1 (fr) | 2008-09-01 |
Family
ID=37631488
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA30794A MA29816B1 (fr) | 2005-09-06 | 2008-03-31 | Composes de benzimidazole thiophene |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US7595330B2 (fr) |
| EP (1) | EP1937671B1 (fr) |
| JP (1) | JP5002597B2 (fr) |
| KR (1) | KR20080047585A (fr) |
| AR (1) | AR055616A1 (fr) |
| AT (1) | ATE452132T1 (fr) |
| AU (1) | AU2006287766B2 (fr) |
| BR (1) | BRPI0615668A2 (fr) |
| CA (1) | CA2621879A1 (fr) |
| CR (1) | CR9786A (fr) |
| CY (1) | CY1109916T1 (fr) |
| DE (1) | DE602006011192D1 (fr) |
| DK (1) | DK1937671T3 (fr) |
| EA (1) | EA014111B1 (fr) |
| ES (1) | ES2337929T3 (fr) |
| HR (1) | HRP20100122T1 (fr) |
| IL (1) | IL189897A0 (fr) |
| JO (1) | JO2578B1 (fr) |
| MA (1) | MA29816B1 (fr) |
| MX (1) | MX2008003173A (fr) |
| NO (1) | NO20081160L (fr) |
| NZ (1) | NZ566345A (fr) |
| PE (1) | PE20070518A1 (fr) |
| PL (1) | PL1937671T3 (fr) |
| PT (1) | PT1937671E (fr) |
| SI (1) | SI1937671T1 (fr) |
| TW (1) | TW200800967A (fr) |
| WO (1) | WO2007030361A2 (fr) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009538305A (ja) * | 2006-05-23 | 2009-11-05 | バーテックス ファーマシューティカルズ インコーポレイテッド | プロテインキナーゼのインヒビターとして有用なチオフェンカルボキサミド |
| US20090326029A1 (en) * | 2006-06-02 | 2009-12-31 | Kevin Wayne Kuntz | Non-cyclic substituted benzimidazole thiophene benzyl ether compounds |
| PE20080710A1 (es) * | 2006-06-02 | 2008-08-07 | Smithkline Beecham Corp | Compuestos de tiofeno de bencimidazol |
| US7615643B2 (en) | 2006-06-02 | 2009-11-10 | Smithkline Beecham Corporation | Benzimidazole thiophene compounds |
| EP2123627B1 (fr) * | 2007-01-19 | 2013-11-20 | Ube Industries, Ltd. | Procédé de production d'amine aromatique ayant un groupe aralkyloxy ou hétéroaralkyloxy |
| JP2010531887A (ja) * | 2007-06-26 | 2010-09-30 | グラクソスミスクライン エルエルシー | ベンズイミダゾールチオフェンの調製方法 |
| WO2009003911A1 (fr) * | 2007-06-29 | 2009-01-08 | 4Sc Ag | Thiophène-imidazopyridines |
| EP2100894A1 (fr) | 2008-03-12 | 2009-09-16 | 4Sc Ag | Pyridopyrimidinones utilisés comme inhibiteurs de la kinase de type Plk1 (polo-like kinase) |
| WO2009151914A1 (fr) * | 2008-05-27 | 2009-12-17 | Smithkline Beecham Corporation | Procédés de traitement de néoplasmes au moyen d'une combinaison d'un inhibiteur de plk et d'un rétinoïde |
| WO2009154645A1 (fr) * | 2008-06-20 | 2009-12-23 | Smithkline Beecham Corporation | Méthodes permettant de traiter des tumeurs du système nerveux central |
| JP2012512223A (ja) | 2008-12-18 | 2012-05-31 | エフ．ホフマン−ラ ロシュ アーゲー | チアゾリル−ベンズイミダゾール類 |
| WO2011049625A1 (fr) | 2009-10-20 | 2011-04-28 | Mansour Samadpour | Procédé de criblage d'aflatoxine dans des produits |
| LT2496567T (lt) | 2009-11-05 | 2017-11-27 | Rhizen Pharmaceuticals S.A. | Nauji benzopirano kinazės moduliatoriai |
| PT2705029T (pt) | 2011-05-04 | 2019-02-01 | Rhizen Pharmaceuticals S A | Novos compostos como moduladores de proteína quinases |
| PT2870157T (pt) | 2012-07-04 | 2017-11-27 | Rhizen Pharmaceuticals S A | Inibidores seletivos de delta pi3k |
| US20230158158A1 (en) | 2020-03-27 | 2023-05-25 | Uppthera | Pyrazolo quinazoline derivative compounds inducing selective degradation of plk1 |
| KR102574152B1 (ko) * | 2020-03-27 | 2023-09-05 | (주) 업테라 | Plk1의 선택적 분해를 유도하는 벤즈이미다졸 티오펜 유도체 화합물 |
| KR20260019479A (ko) | 2023-05-04 | 2026-02-10 | 레볼루션 메디슨즈, 인크. | Ras 관련 질환 또는 장애를 위한 병용 요법 |
| CN121889155A (zh) | 2023-08-07 | 2026-04-17 | 锐新医药公司 | 用于治疗ras蛋白相关疾病或病症的rmc-6291 |
| AU2024360465A1 (en) | 2023-10-12 | 2026-04-09 | Revolution Medicines, Inc. | Macrocyclic ras inhibitors |
| WO2025171296A1 (fr) | 2024-02-09 | 2025-08-14 | Revolution Medicines, Inc. | Inhibiteurs de ras |
| WO2025240847A1 (fr) | 2024-05-17 | 2025-11-20 | Revolution Medicines, Inc. | Inhibiteurs de ras |
| US20250375445A1 (en) | 2024-06-07 | 2025-12-11 | Revolution Medicines, Inc. | Methods of treating a ras protein-related disease or disorder |
| WO2025265060A1 (fr) | 2024-06-21 | 2025-12-26 | Revolution Medicines, Inc. | Compositions thérapeutiques et procédés de gestion d'effets liés au traitement |
| WO2026006747A1 (fr) | 2024-06-28 | 2026-01-02 | Revolution Medicines, Inc. | Inhibiteurs de ras |
| WO2026015825A1 (fr) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Utilisation d'un inhibiteur de ras pour traiter le cancer du pancréas |
| WO2026015796A1 (fr) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Méthodes de traitement d'une maladie ou d'un trouble lié à ras |
| WO2026015790A1 (fr) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Méthodes de traitement d'une maladie ou d'un trouble lié à ras |
| WO2026015801A1 (fr) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Méthodes de traitement d'une maladie ou d'un trouble liés à ras |
| WO2026050446A1 (fr) | 2024-08-29 | 2026-03-05 | Revolution Medicines, Inc. | Inhibiteurs de ras |
| WO2026072904A2 (fr) | 2024-09-26 | 2026-04-02 | Revolution Medicines, Inc. | Compositions et méthodes de traitement du cancer du poumon |
| WO2026090116A2 (fr) | 2024-10-21 | 2026-04-30 | Revolution Medicines, Inc. | Inhibiteurs de ras |
| US20260108528A1 (en) | 2024-10-22 | 2026-04-23 | Revolution Medicines, Inc. | Methods of treating a ras protein-related disease or disorder |
| WO2026090245A1 (fr) | 2024-10-22 | 2026-04-30 | Revolution Medicines, Inc. | Utilisation d'inhibiteurs ras pour traiter un cancer |
| WO2026106912A1 (fr) | 2024-11-12 | 2026-05-21 | Revolution Medicines, Inc. | Inhibiteurs de ras |
| WO2026112260A1 (fr) | 2024-11-21 | 2026-05-28 | Revolution Medicines, Inc. | Inhibiteurs de ras |
| WO2026122764A2 (fr) | 2024-12-06 | 2026-06-11 | Revolution Medicines, Inc. | Inhibiteurs de ras |
| WO2026128688A2 (fr) | 2024-12-13 | 2026-06-18 | Revolution Medicines, Inc. | Inhibiteurs de ras |
| WO2026161839A1 (fr) | 2025-01-27 | 2026-07-30 | Revolution Medicines, Inc. | Inhibiteurs de ras |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5990146A (en) | 1997-08-20 | 1999-11-23 | Warner-Lambert Company | Benzimidazoles for inhibiting protein tyrosine kinase mediated cellular proliferation |
| US6162804A (en) * | 1997-09-26 | 2000-12-19 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| CA2341409A1 (fr) | 1998-08-31 | 2000-03-09 | Merck And Co., Inc. | Nouveaux inhibiteurs d'angiogenese |
| MXPA05001544A (es) * | 2002-08-08 | 2005-04-19 | Smithkline Beecham Corp | Compuestos de tiofeno. |
| AU2003903440A0 (en) * | 2003-07-04 | 2003-07-17 | James Hardie International Finance B.V. | Rainscreen apparatus and method |
| EP1685128A1 (fr) * | 2003-10-16 | 2006-08-02 | Smithkline Beecham Corporation | Procede de preparation de thiophenes de benzimidazole |
| JP4721428B2 (ja) | 2003-10-20 | 2011-07-13 | 日本精工株式会社 | ステアリング装置 |
| GB0402809D0 (en) | 2004-02-09 | 2004-03-10 | Glaxo Group Ltd | Chemical compounds |
| EP1924572B1 (fr) * | 2005-09-06 | 2009-12-30 | SmithKline Beecham Corporation | Procede regioselectif de preparation de benzimidazole thiophenes |
| JP2009507020A (ja) * | 2005-09-06 | 2009-02-19 | スミスクライン ビーチャム コーポレーション | Ｐｌｋ調節物質としてのルベンゾイミダゾールチオフェン化合物 |
| EP2474546A1 (fr) | 2006-01-23 | 2012-07-11 | Vertex Pharmaceuticals Inc. | Tiophène-carboxamides utiles en tant qu'inhibiteurs de kinases de protéine |
| PE20080710A1 (es) * | 2006-06-02 | 2008-08-07 | Smithkline Beecham Corp | Compuestos de tiofeno de bencimidazol |
| US20090326029A1 (en) * | 2006-06-02 | 2009-12-31 | Kevin Wayne Kuntz | Non-cyclic substituted benzimidazole thiophene benzyl ether compounds |
-
2006
- 2006-08-28 MX MX2008003173A patent/MX2008003173A/es active IP Right Grant
- 2006-08-28 US US11/467,577 patent/US7595330B2/en not_active Expired - Fee Related
- 2006-08-28 DK DK06813896.5T patent/DK1937671T3/da active
- 2006-08-28 PL PL06813896T patent/PL1937671T3/pl unknown
- 2006-08-28 NZ NZ566345A patent/NZ566345A/en not_active IP Right Cessation
- 2006-08-28 JO JO2006286A patent/JO2578B1/en active
- 2006-08-28 SI SI200630582T patent/SI1937671T1/sl unknown
- 2006-08-28 ES ES06813896T patent/ES2337929T3/es active Active
- 2006-08-28 KR KR1020087007794A patent/KR20080047585A/ko not_active Ceased
- 2006-08-28 TW TW095131590A patent/TW200800967A/zh unknown
- 2006-08-28 WO PCT/US2006/033683 patent/WO2007030361A2/fr not_active Ceased
- 2006-08-28 BR BRPI0615668-1A patent/BRPI0615668A2/pt not_active IP Right Cessation
- 2006-08-28 US US12/065,668 patent/US7786127B2/en not_active Expired - Fee Related
- 2006-08-28 HR HR20100122T patent/HRP20100122T1/hr unknown
- 2006-08-28 JP JP2008529190A patent/JP5002597B2/ja not_active Expired - Fee Related
- 2006-08-28 EP EP06813896A patent/EP1937671B1/fr not_active Not-in-force
- 2006-08-28 AR ARP060103742A patent/AR055616A1/es not_active Application Discontinuation
- 2006-08-28 CA CA002621879A patent/CA2621879A1/fr not_active Abandoned
- 2006-08-28 AT AT06813896T patent/ATE452132T1/de active
- 2006-08-28 PE PE2006001041A patent/PE20070518A1/es not_active Application Discontinuation
- 2006-08-28 DE DE602006011192T patent/DE602006011192D1/de active Active
- 2006-08-28 EA EA200800546A patent/EA014111B1/ru not_active IP Right Cessation
- 2006-08-28 PT PT06813896T patent/PT1937671E/pt unknown
- 2006-08-28 AU AU2006287766A patent/AU2006287766B2/en not_active Ceased
-
2008
- 2008-02-29 CR CR9786A patent/CR9786A/es not_active Application Discontinuation
- 2008-03-03 IL IL189897A patent/IL189897A0/en unknown
- 2008-03-05 NO NO20081160A patent/NO20081160L/no not_active Application Discontinuation
- 2008-03-31 MA MA30794A patent/MA29816B1/fr unknown
-
2010
- 2010-03-09 CY CY20101100224T patent/CY1109916T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JO2578B1 (en) | Compounds Theophene benzimidazole | |
| JO3408B1 (ar) | مركبات بترين سلفون اميد ثيازول و أوكسازول | |
| MA30042B1 (fr) | Composes calcilytiques | |
| MA31606B1 (fr) | Anticorps anti-cd 79b immunoconjugues et procedes d'utilisation | |
| MA30765B1 (fr) | Derives innovants du thiophene | |
| ATE517883T1 (de) | Imidazolderivate als funktionelle selektive agonisten des alpha2c-adrenorezeptors | |
| MA33208B1 (fr) | Anticorps anti-fgfr3 et procédés d'utilisation de ceux-ci | |
| MX2009005462A (es) | Analogos de 7,8-saturados-4,5-epoxi-morfinano. | |
| MA31605B1 (fr) | Anticorps anti-cd79b humanisés, immunoconjugués, et procédés d'utilisation | |
| MA31907B1 (fr) | Nouveaux herbicides | |
| ATE536355T1 (de) | 3,3-spiroindolinionderivate als antikrebsmittel | |
| EP2200573A4 (fr) | Composés de férulate de resvératrol, compositions contenant lesdits composés et leurs procédés d'utilisation | |
| MXPA05007328A (es) | Composiciones que contienen agentes antiacne y el uso de las mismas. | |
| ATE447568T1 (de) | Neue pyrinderivate | |
| EP2066689A4 (fr) | Peptides hyd1 en tant qu'agents anticancereux | |
| EP2205218A4 (fr) | Composition pharmaceutique contenant de l'ésoméprazole | |
| EP2217063A4 (fr) | Paclitaxels thiolés destinés à réagir avec des nanoparticules d'or, servant d'agents de distribution de médicaments | |
| MA30331B1 (fr) | ANTICORPS à EFGL 7 ET LEURS PROCEDES D'UTILISATION | |
| TW200716605A (en) | 2,6-quinolinyl derivatives, processes for preparing them and their uses | |
| ATE459620T1 (de) | Benzimidazolthiophenverbindungen als plk- modulatoren | |
| MA39163B1 (fr) | Forme cristalline de (s)-(2-(6-chloro-7-methyl-1h-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1 -yl)(5-methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone et utilisation de celle-ci en tant qu'antagonistes des recepteurs de l'orexine | |
| EP2285215A4 (fr) | Nouveaux composés, compositions pharmaceutiques contenant ceux-ci, et procédés d'utilisation de ceux-ci | |
| FR2894143B1 (fr) | Composition a liberation prolongee de l'actif, son procede de preparation et son utilisation. | |
| WO2008070354A3 (fr) | Benzidimidazole thiophènes substitués en 5 et 6 pour plk | |
| EP2020223A3 (fr) | Produit de soin capillaire ayant une teneur en diamants |